Beckman Coulter Announces Release of Three New Work Cells
Systems Feature Unique Closed-Tube Sampling Technology

Beckman Coulter has launched three new systems, completing the company’s family of integrated chemistry-immunoassay work cells. The new systems range from high volume to very high volume: UniCel® DxC 660i Synchron® Access® Clinical System, UniCel DxC 680i and UniCel DxC 860i.

Every one of the five integrated systems—each targeted to a different test mix and volume—allows laboratories to perform both chemistry and immunoassay testing simultaneously from a single sample with a single point of entry. According to Scott Atkin, group vice president of Beckman Coulter’s Chemistry and Clinical Lab Automation business group, “We’ve used our industry-leading systems integration capability to deliver a range of systems which offer labs tremendous flexibility in addressing their needs. Our work cells have the potential to enhance hospital efficiency by increasing lab productivity, improving patient health and reducing the cost of care.”

UniCel DxC chemistry systems or UniCel DxI immunoassay systems already installed in laboratories may be upgraded to a new work cell configuration. This flexible approach allows laboratories to select a Beckman Coulter system with confidence, knowing they can adapt their system to changing work load requirements.

Beckman Coulter is the only instrument manufacturer to offer ClozCap™ technology—closed-tube sampling and aliquotting—which allows laboratories to eliminate labor-intensive de-capping, re-capping and sample splitting steps, increasing lab efficiency and operator safety. The systems also offer a comprehensive menu of more than 150 different tests, ranging from cardiac and tumor markers to tests for renal function, diabetes and more.